Last reviewed · How we verify
NCT06707155
Digital Tracking With Auto Data Reporting
trial in Type 1 Diabetes Mellitus (T1DM) in 25 participants. Completed in 4 January 2025.
4 January 2025
Quick facts
| Lead sponsor | Persei Vivarium |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 25 |
| Start date | 22 July 2024 |
| Primary completion | 4 January 2025 |
| Estimated completion | 4 January 2025 |
| Sites | 1 location across Spain |
Conditions studied
- Type 1 Diabetes Mellitus (T1DM) — all drugs for Type 1 Diabetes Mellitus (T1DM) →
Sponsor
Persei Vivarium
Who can join
3 and older, any sex, with Type 1 Diabetes Mellitus (T1DM). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Type 1 diabetes mellitus is a chronic pathology and represents a constant challenge for children and adolescents with diabetes and their families. The objective of the treatment of DM1 in pediatric age is to achieve and maintain an optimal glycemic control in order to avoid or delay chronic micro- and macrovascular complications related to the disease. However, currently, despite technological advances and the development of new insulin formulations, the majority of patients are unable to achieve glycemic goals. In this context, the use of digital tools/platforms that allow remote monitoring of patients and that facilitate telemedicine have shown potential to improve treatment adherence and facilitate continued therapeutic education, improving clinical results with savings in time and associated costs.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06707155
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Type 1 Diabetes Mellitus (T1DM)
Currently open trials in the same condition.
- NCT07195045 — Thai PainPREDICT Validation Study · NA · recruiting
- NCT06984133 — Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes · NA · recruiting
- NCT07086989 — Cardiovascular Risk in Children With Chronic Conditions Study · recruiting
- NCT06883318 — Physical, Psychological and Socioeconomic Effects of Childhood Onset Diabetes in Sweden · active not recruiting
Other Persei Vivarium trials
Trials by the same sponsor.
- NCT06869408 — Observational Study on the Patient's Ability to Use a Digital Platform in Heart Failure · completed
- NCT06745401 — Remote Monitoring of Cancer Patients With Outpatient Treatment · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06707155 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Persei Vivarium
- Last refreshed: 5 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06707155.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing